Author

Ai Vu Hong

InsermORCID 0000-0002-0872-4295Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

David IsraeliiD· 2 shared Isabelle RichardiD· 2 shared Abbass JaberiD· 1 shared Adeline Miranda· 1 shared Daniel StockholmiD· 1 shared Elise LachiveriD· 1 shared Fatima Amor· 1 shared Guillaume CorreiD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

David IsraeliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologybioRxivPreprintFeb 11, 2025

Targeting lysosomal damage is a new therapeutic perspective for Duchenne Muscular Dystrophy

Abbass Jaber, Laura Palmieri, Rania Bakour…·David Israeli

This study identifies lysosomal damage as a novel mechanism in Duchenne Muscular Dystrophy and shows that combining trehalose with gene therapy improves outcomes.

DOI 10.1101/2025.02.11.637610

mousebulk RNA-seq

𝕏 PostBluesky

GeneticsJournal of Cachexia Sarcopenia and MusclePeer-reviewedMay 26, 2021

Cholesterol metabolism is a potential therapeutic target in Duchenne Muscular Dystrophy

Fatima Amor, Ai Vu Hong, Guillaume Corre…·David Israeli

This study identifies dysregulated miRNAs in DMD patients and mice, linking cholesterol metabolism and the mevalonate pathway to disease progression, with Simvastatin treatment showing therapeutic potential.

67 citationstop 4%

mousehuman

𝕏 PostBluesky